These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8907721)

  • 1. Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma.
    Ferdous AJ; Ishida T; Shinohara M; Harashima H; Kiwada H
    Biopharm Drug Dispos; 1996 Mar; 17(2):145-54. PubMed ID: 8907721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling.
    Harashima H; Hiraiwa T; Ochi Y; Kiwada H
    J Drug Target; 1995; 3(4):253-61. PubMed ID: 8820999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ.
    Matsuo H; Funato K; Harashima H; Kiwada H
    J Drug Target; 1994; 2(2):141-6. PubMed ID: 8069591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of the interaction between liposomes and the complement system in rat serum: re-evaluation of size-dependency.
    Yamada M; Harashima H; Kiwada H
    Biol Pharm Bull; 1998 Sep; 21(9):964-8. PubMed ID: 9781848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors of elimination of liposome-encapsulated drug model substances after intravenous administration].
    Kibat P; Stricker H
    Arzneimittelforschung; 1988 Oct; 38(10):1472-8. PubMed ID: 3196388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced permeability of freeze-dried liposomal bilayers upon rehydration.
    Zhang W; van Winden EC; Bouwstra JA; Crommelin DJ
    Cryobiology; 1997 Nov; 35(3):277-89. PubMed ID: 9367615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of liposome-incorporated carboxyfluorescein in rabbit eyes.
    Hirnle E; Hirnle P; Wright JK
    J Microencapsul; 1991; 8(3):391-9. PubMed ID: 1941446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential value of cetylmannoside-modified liposomes as carriers of macrophage activators to human blood monocytes.
    Yamashita C; Sone S; Ogura T; Kiwada H
    Jpn J Cancer Res; 1991 May; 82(5):569-76. PubMed ID: 1905703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cetylmannoside modification on the alternative complement pathway activation by liposomes in rat serum.
    Matsuo H; Yamashita C; Akiyama K; Kiwada H
    Biol Pharm Bull; 1995 Apr; 18(4):581-5. PubMed ID: 7655432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma factor triggering alternative complement pathway activation by liposomes.
    Funato K; Yamashita C; Kamada J; Tominaga S; Kiwada H
    Pharm Res; 1994 Mar; 11(3):372-6. PubMed ID: 8008701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes.
    Sandström MC; Ickenstein LM; Mayer LD; Edwards K
    J Control Release; 2005 Sep; 107(1):131-42. PubMed ID: 16023753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers.
    Shehata T; Ogawara K; Higaki K; Kimura T
    Int J Pharm; 2008 Jul; 359(1-2):272-9. PubMed ID: 18486370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty alcohols or fatty acids as niosomal hybrid carrier: effect on vesicle size, encapsulation efficiency and in vitro dye release.
    Bandyopadhyay P; Johnson M
    Colloids Surf B Biointerfaces; 2007 Jul; 58(1):68-71. PubMed ID: 17339104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units.
    Momekova D; Rangelov S; Yanev S; Nikolova E; Konstantinov S; Romberg B; Storm G; Lambov N
    Eur J Pharm Sci; 2007 Dec; 32(4-5):308-17. PubMed ID: 17928206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of cultured human keratinocytes with liposomes encapsulating silver sulphadiazine: proof of the uptake of intact vesicles.
    Schaller M; Korting HC; Schmid MH
    Br J Dermatol; 1996 Mar; 134(3):445-50. PubMed ID: 8731667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-nucleus interactions. Flow cytometric study on the role of the nuclear surface.
    Caramelli E; Papa S; Billi AM; Vitale M; Bartoletti A; Manzoli L; Capitani S
    Cell Biochem Funct; 1989 Jan; 7(1):71-4. PubMed ID: 2752539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles.
    Nounou MM; El-Khordagui LK; Khalafallah N
    Acta Pol Pharm; 2005; 62(5):369-79. PubMed ID: 16459486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of immunoproteins in the survival of liposomes in the circulation.
    Devine DV; Marjan JM
    Crit Rev Ther Drug Carrier Syst; 1997; 14(2):105-31. PubMed ID: 9107519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic modelling of liposome degradation in serum: effect of size and concentration of liposomes in vitro.
    Harashima H; Ochi Y; Kiwada H
    Biopharm Drug Dispos; 1994 Apr; 15(3):217-25. PubMed ID: 7880982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.